Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia;Utilisation du temps de coagulation par l'écarine en sang total pour la surveillance d'un traitement anticoagulant par lépirudine (Refludan®) au cours de circulation extracorporelle dans un contexte de thrombopénie induite par l'héparine

Annales de Biologie Clinique

Volumn 63, Issue 2, 2005, Pages 201-208

  Devignes, J ^a   De Maistre, E ^a   Grosjean, S ^a   Fohlen Walter, A ^a   Hacquard, M ^a   Mulot, A ^a   Longrois, D ^a   Carteaux, J P ^a   Lecompte, T ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cardiopulmonary bypass; Ecarin clotting time; Heparin induced thrombocytopenia; Hirudin

Indexed keywords

ANTICOAGULANT AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ECARIN; ENZYME PRECURSOR; FIBRINOLYTIC AGENT; HEPARIN; HIRUDIN DERIVATIVE; LEPIRUDIN; MEIZOTHROMBIN; PROTEINASE; RECOMBINANT PROTEIN; THROMBIN; VIPER VENOM;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TEST; CARDIOPULMONARY BYPASS; CASE REPORT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROTHROMBIN TIME; THROMBOCYTOPENIA; THROMBOSIS; TIME;

AGED; ANTICOAGULANTS; BLOOD COAGULATION TESTS; CARDIOPULMONARY BYPASS; ENDOPEPTIDASES; ENZYME PRECURSORS; FIBRINOLYTIC AGENTS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; PROTHROMBIN TIME; RECOMBINANT PROTEINS; THROMBIN; THROMBOCYTOPENIA; THROMBOSIS; TIME FACTORS; VIPER VENOMS;

ECHIS CARINATUS; SERPENTES;

EID: 15944375518     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Greinacher A, Völpel H, Pötzsch B. Recombinant hirudin in the treatment of patients with heparin-associated thrombocytopenia type II (HAT). Ann Haemat 1996 ; 72 : A92.
2. Pötzsch B, Madlener K, Seelig C, Riess CF, Greinacher A, Müller-Berghaus G. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-assessment of the whole blood ecarin clotting time. Thromb Haemost 1997 ; 77 : 920-5.
3. Greinacher A, Völpel H, Janssens U, et al. Recombinant hirudin (Lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. A prospective study. Circulation 1999 ; 99 : 73-80.
4. Kher A, Gouin I, Samama MM. Surveillance du traitement par les inhiniteurs directs de la thrombine : temps de céphaline avec activateur ou temps d'écarine. Ann Biol Clin 2000 ; 58 : 575-9.
5. Koster A, Kuppe H, Hetzer R, Sodian R, Crystal GJ, Mertzlufft F. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin. Anesthesiology 1998 ; 89 : 777-80.
6. Rhee MJ, Morris S, Kosow DP. Role of meizothrombin and meizothrombin-(des F1) in the conversion of prothrombin to thrombin by Echis carinatus venom coagulant. Biochemistry 1982 ; 21 : 3437-43.
7. Pötzsch B, Hund S, Madlener K, Unkrig C, Müller-Berghaus G. Monitoring of recombinant hirudin : assessment of a plasma-based ecarin clotting time assay. Thromb Res 1997 ; 86 : 373-83.
8. Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : a 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 2000 ; 14 : 243-8.
9. Longrois D, de Maistre E, Bischoff N, et al. Recombinant hirudin anticoagulation for aortic valve replacement in heparin induced thrombocytopenia. Can J Anesth 2000 ; 47 : 255-60.
10. Boinot C, Lanquetot H, Macchi L, Charrière JM, Menu P. Circulation extracorporelle sous lépirudine (Refludan®) dans un contexte de thrombopénie induite par l'héparine. Ann Fr Anesth Reanim 2003 ; 22 : 635-8.
11. Vassault A, Azzedinz MC, Bailly M, et al. Protocole de validation de techniques (document B, stade 3). Commission « Validation de techniques ». Ann Biol Clin 1986 ; 44 : 688-711.
12. Bouyer J. Régression linéaire. In : Méthodes statistiques en médecine et biologie. Paris : Estem, Editions Inserm, 1997 : 177-206.
13. Poetzsch B, Madlener K. Management of cardiopulmonary bypass anticoagulation in patients with heparin-induced thrombocytopenia. In : Heparin-induced thrombocytopenia. New York : Dekker, 2003 : 531-51.
14. Warkentin TE, Greinacher A. Heparin induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003 ; 76 : 2121-31.